Ventana Biotech, Inc.
VNTA
Other OTC0.04
USD
- -
- -
ISIN
US92277F2083
CUSIP
92277F208
Return %
Stock
S&P500
1Y
53.65
26.53
3Y
-96.92
76.60
5Y
-97.74
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Janne Christensen
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1 Bachstrasse Denver Switzerland 9606
- IPO Date
- Sep 8, 2009
- Website
- launchpadcafe.net
- Similar Companies
- Business
- Ventana Global Inc. (VNTA), formerly Ventana Biotech Inc., operates as a financial services company servicing a diverse portfolio of loans and providing consulting services to third-party businesses; its core offerings include custom financial solutions, borrower and lender networking, business advising, mentoring, ethical hard money loans secured by various collateral types, and strategic planning assistance for entrepreneurs seeking alternative funding when traditional lenders decline. The company, founded in 1989 and headquartered in Butschwil, Switzerland, targets small businesses and entrepreneurs across the United States through a nationwide network of lenders, emphasizing rapid turnaround funding, management team gap-filling via expert advisors, and comprehensive support in business formation, growth, and funding strategies. In recent developments, Ventana Biotech completed the acquisition of LaunchPad Café Ltd., shifting its strategic focus from biotechnology drug development to financial services and loan brokering, while implementing a 1-for-20 reverse stock split to adjust its share structure and enhance market positioning.
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Ventana Global, Inc. (VNTA) Reports Fiscal Year 2025 Results and Publishes Annual Report; Discloses Initial Lending Activity
Ventana Biotech, Inc. (VNTAD) Announces Name Change to Ventana Global, Inc. and Significant Outstanding Share Reduction